GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Whanin Pharm Co Ltd (XKRX:016580) » Definitions » EBITDA Margin %

Whanin Pharm Co (XKRX:016580) EBITDA Margin % : 11.45% (As of Sep. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Whanin Pharm Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Whanin Pharm Co's EBITDA for the three months ended in Sep. 2024 was ₩7,802 Mil. Whanin Pharm Co's Revenue for the three months ended in Sep. 2024 was ₩68,113 Mil. Therefore, Whanin Pharm Co's EBITDA margin for the quarter that ended in Sep. 2024 was 11.45%.


Whanin Pharm Co EBITDA Margin % Historical Data

The historical data trend for Whanin Pharm Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Whanin Pharm Co EBITDA Margin % Chart

Whanin Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.19 20.49 21.45 17.45 17.57

Whanin Pharm Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.64 15.50 21.06 15.17 11.45

Competitive Comparison of Whanin Pharm Co's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Whanin Pharm Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Whanin Pharm Co's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Whanin Pharm Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Whanin Pharm Co's EBITDA Margin % falls into.



Whanin Pharm Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Whanin Pharm Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=40475.358/230393.579
=17.57 %

Whanin Pharm Co's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=7801.616/68113.499
=11.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Whanin Pharm Co  (XKRX:016580) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Whanin Pharm Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Whanin Pharm Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Whanin Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
84-1 Munjeong-dong, Songpa-gu, Seoul, KOR, 138-200
Whanin Pharm Co Ltd is a pharmaceutical company. The company develops, manufactures, markets, and sells the therapeutic products. It offers antibiotics, cardiovascular drugs, CNS stimulants, gastrointestinal drugs, multivitamins and other products. The company's products include Antiasthmatics; Antidepressants; Antipsychotics; Anxiolytics and hypnotics; and Antiepileptics.

Whanin Pharm Co Headlines

No Headlines